Health care use and costs in the decade after identification of type 1 and type 2 diabetes: A population-based study

Diabetes Care

Volumn 29, Issue 11, 2006, Pages 2403-2408

  Johnson, Jeffrey A ^a,b   Pohar, Sheri L ^a   Majumdar, Sumit R ^a,b  

^a INSTITUTE OF HEALTH ECONOMICS   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DRUG USE; FEMALE; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE;

ADULT; AGED; AMBULATORY SURGICAL PROCEDURES; CANADA; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DRUG COSTS; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PHYSICIANS; PREVALENCE; RENAL DIALYSIS; RESOURCE ALLOCATION;

EID: 33845508654     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0735     Document Type: Article

References (24)

1. Ettaro L, Songer TJ, Zhang P, Engelgau MM: Cost-of-illness studies in diabetes mellitus. Pharmacoeconomics 22:149-164,2004
2. Hogan P, Dall T, Nikolov P: Economic costs of diabetes in the U.S. in 2002. Diabetes Care 26:917-932, 2003
3. Dawson KG, Gomes D, Gerstein H, Blanchard JF, Kahler KH: The economic cost of diabetes in Canada, 1998. Diabetes Care 25:1303-1307, 2002
4. Health Canada: Responding to the Challenge of Diabetes in Canada: First Report of the National Diabetes Surveillence System (NDSS). Ottawa., Canada, Health Canada, 2003
5. Brown JB, Nichols GA, Glauber HS, Bakst AW: Type 2 diabetes: incremental medical care costs during the first 8 years after diagnosis. Diabetes Care 22:1116-1124, 1999
6. Nichols GA, Glauber HS, Brown JB: Type 2 diabetes: incremental medical care costs during the 8 years preceding diagnosis. Diabetes Care 23:1654-1659, 2000
7. Olsen BS, Sjolie A, Hougaard P, Johannesen J, Borch-Johnsen K, Marinelli K, Thorsteinsson B, Pramming S, Mortensen HB: A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes: risk markers for the development of retinopathy, nephropathy and neuropathy: Danish Study Group of Diabetes in Childhood. J Diabetes Complications 14:295-300, 2000
8. Bjork S: The cost of diabetes and diabetes care. Diabetes Res Clin Pract 54 (Suppl. 1):S13-S18, 2001
9. Caro JJ, Ward AJ, O'Brien JA: Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care 25:476-481, 2002
10. Simpson SH, Corabian P, Jacobs P, Johnson JA: The cost of major comorbidity in people with diabetes mellitus. CMAJ 168:1661-1667, 2003
11. Statistics Canada: Consumer price index (CPI), 2001 basket content, annual [article online], 2006. Available from www.statscan.ca. Accessed 20 September 2006
12. Pohar SL, Simpson SH, Majumdar SR, Jacobs P, Ohinmaa A, Osei W, Stang M, Downey W, Johnson JA: Epidemiologic and Cost Trends in Diabetes in Saskatchewan, 1991 to 2001. Edmonton, Canada, Alliance for Canadian Health Outcomes Research in Diabetes, 2006 (Institute of Health Economics Working Paper 05-06)
13. Johnson JA, Simpson SH, Jacobs P, Downey W, Beck P, Osei W: Cost of Health Care for People With Diabetes Mellitus in Saskatchewan 1991 to 1996. Edmonton, Alliance for Canadian Health Outcomes Research in Diabetes, 2002 (Institute of Health Economics Working Paper 02-02)
14. Lee H, Manns B, Taub K, Ghali WA, Dean S, Johnson D, Donaldson C: Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 40:611-622, 2002
15. Engelgau MM, Geiss LS, Saaddine JB, Boyle JP, Benjamin SM, Gregg EW, Tierney EF, Rios-Burrows N, Mokdad AH, Ford ES, Imperatore G, Narayan KM: The evolving diabetes burden in the United States. Ann Intern Med 140:945-950, 2004
16. Pohar SL, Majumdar SR, Jacobs P, Johnson JA: Healthcare Utilization and Direct Healthcare Costs of Diabetes in Urban and Rural Saskatchewan, 1991-2001. Edmonton, Canada, Alliance for Canadian Health Outcomes Research in Diabetes, 2006 (Institute of Health Economics Working Paper WP 06-01)
17. Liu L, Hader J, Brossart B, White R, Lewis S: Impact of rural hospital closures in Saskatchewan, Canada. Soc Sci Med 52:1793-1804, 2001
18. Morgan SG, Bassett KL, Wright JM, Evans RG, Barer ML, Caetano PA, Black CD: "Breakthrough" drugs and growth in expenditure on prescription drugs in Canada. BMJ 331:815-816, 2005
19. Klinke JA, Johnson JA, Guirguis LM, Toth EL, Lee TK, Lewanczuk RZ, Majumdar SR: Underuse of aspirin in type 2 diabetes mellitus: prevalence and correlates of therapy in rural Canada. Clin Ther 26:439-446, 2004
20. Brown LC, Johnson JA, Majumdar SR, Tsuyuki RT, McAlister FA: Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ 171:1189-1192, 2004
21. Hux JE, Ivis F, Flintoft V, Bica A: Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 25:512-516, 2002
22. LaPorte RE, Matsushima M, Chang YF: Prevalence and incidence of insulin-dependent diabetes [article online], 1995. Available from http://diabetes.niddk.nih.gov/dm/pubs/america/pdf/chapter3.pdf. Accessed 13 December 2005
23. Kenny SJ, Aubert RE, Geiss LS: Prevalence and incidence of non-insulin dependent diabetes [article online], 1995. Available from diabetes.niddk.nih. gov/dm/pubs/america/pdf/chapter4.pdf. Accessed 13 December 2005
24. Gross CP, Anderson GF, Powe NR: The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med 340:1881-1887, 1999